Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-090198

Chief Executive Officer acquired 42,826 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2025-06-25 Grant or award +42,826 $4.67 $199,997 268,566 D: show line 1 in the form
Loading xslF345X05/ownership.xml…